9,9'-(2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-phenylene)bis(9H-carbazole)

Catalog No. :
ACYHXO316
CAS No. :
2674061-90-4
Molecular Formula :
C36H31BN2O2
Molecular Weight :
534.47

IUPAC Name:9,9'-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-phenylene)bis(9H-carbazole)

9,9'-(2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-phenylene)bis(9H-carbazole) structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name9,9'-(2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-phenylene)bis(9H-carbazole)
IUPAC Name9,9'-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-phenylene)bis(9H-carbazole)
Molecular FormulaC36H31BN2O2
Molecular Weight534.47
SMILESO1B(OC(C)(C)C1(C)C)C=2C(=CC=CC2N3C=4C=CC=CC4C=5C=CC=CC53)N6C=7C=CC=CC7C=8C=CC=CC86
InChI KeySTNTXBCAJIQJQO-UHFFFAOYSA-N
Synonym9,9'-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-phenylene)bis(9H-carbazole)
CAS No.2674061-90-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACYHXO316 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQALD394 route compound structure diagram
    ACQALD3942227146-17-8 In Stock
  2. Plus
  3. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  4. Then
  5. ACYHXO316 route product structure diagram
    ACYHXO3162674061-90-4
Inquiry

2. ACYHXO316 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACYHXO316 route product structure diagram
    ACYHXO3162674061-90-4
Inquiry

Comments (0)